Adam Smith, U.S. Representative

Adam Smith

WA09houseFiled Aug 8, 2025

Adam Smith (WA) sold $1K-$15K of $ABBNY (ABB LTD SPONS ADR) on Aug 8, 2025, part of 18 transactions in this filing.

HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.

Transactions
18
Companies
18
Largest Trade
$1K-$15K
Timing Flags
5

Companies in this filing · 18

Price Movement Since Trade

How the largest positions have moved from the trade date to the most recent close.

Showing the 6 largest positions. See every transaction in the table below.

Suspicious Timing Detected

5 flags
1.

Adam Smith sold $1,001 - $15,000 in $UPS on 2025-08-08 — 26 days before HR747, the "Stop Chinese Fentanyl Act of 2025," which expands sanctions on Chinese entities involved in opioid and precursor production, a potentially bearish signal for global logistics.

2.

Adam Smith sold $1,001 - $15,000 in $C on 2025-08-08 — 40 days before HR5427, the "Billionaires Income Tax Act," which proposes taxing unrealized gains annually for high-net-worth individuals, potentially impacting financial institutions.

3.

Adam Smith sold $1,001 - $15,000 in $CVS on 2025-08-08 — 41 days before HR5454, the "Medicare Advantage Prompt Pay Act," which mandates stricter payment timelines for Medicare Advantage organizations, potentially affecting healthcare providers.

4.

Adam Smith sold $1,001 - $15,000 in $CVS on 2025-08-08 — 90 days before S976, the "Insurance Fraud Accountability Act," which directly increases civil penalties for agents and brokers providing incorrect or fraudulent information, potentially impacting the insurance sector.

5.

Adam Smith sold $1,001 - $15,000 in $AAPL on 2025-08-08 — 10 days after HR4828, the "Blue Shield Privacy Act of 2025," which expands privacy protections to include biometric data, license plate numbers, workplace/school addresses, potentially impacting technology companies.

These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.

Share This Filing

All Transactions

SELL$1K-$15K
$ABBNYABB LTD SPONS ADR
$66.54 \u2192 N/A
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$ALKAlaska Air Group, Inc. Common Stock
$52.28 \u2192 N/A
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$GOOGAlphabet Inc. - Class C Capital Stock
$202.09 \u2192 N/A
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$AAPLApple Inc. - Common Stock
$229.35 \u2192 N/A
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$BRK.BBerkshire Hathaway Inc. New Common Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$CCitigroup, Inc. Common Stock
$92.73 \u2192 N/A
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$CVSCVS Health Corporation Common Stock
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$DEDeere & Company Common Stock
$510.37 \u2192 N/A
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$MSFTMicrosoft Corporation - Common Stock
$522.04 \u2192 N/A
Aug 8, 2025 \u2022 spouse
SELL$1K-$15K
$NEMNewmont Corporation
$68.98 \u2192 N/A
Aug 8, 2025 \u2022 spouse

Connected Legislative Activity

10 signals

These bills and contracts share tickers or sectors with this filing's trades.

BillHR5111neutral

CRP Improvement and Flexibility Act of 2025

HR5111 is an early-stage procedural bill modifying CRP haying/grazing rules and adding a continuous enrollment practice. It authorizes zero new funding and remains in House subcommittee. Market impact on agriculture-sector tickers is negligible — $ADM, $CTVA, and $DE see no revenue effect based on the legislative text and status.

Jan 13, 2026
ADMCTVADE
BillHR5427bearish

Billionaires Income Tax Act

The Billionaires Income Tax Act (HR 5427) is an early-stage House bill proposing annual mark-to-market taxation of unrealized capital gains for billionaires. Real market data shows alternative asset managers Blackstone and Carlyle trading at $122.51 and $48.94 respectively after 7-day declines of 0.71% and 1.28%, with Carlyle down 6.94% over the past week. BlackRock at $1056.19 bucked the trend with a 7-day gain of 1.07%, reflecting its status as a potential beneficiary of capital rotation from illiquid to liquid assets. The bill remains stuck in committee with 32 cosponsors and no hearings — low probability of passage in the 119th Congress, but the market is already pricing structural risk.

Sep 17, 2025
BLKCMS
BillHR4553bullish

Energy and Water Development and Related Agencies Appropriations Act, 2026

H.R. 4553 directly appropriates $2.755 billion for Army Corps of Engineers civil works — $2.555B for construction and $200M for investigations — creating immediate demand for heavy equipment and construction materials. The bill has passed the House, is on the Senate Legislative Calendar, and has high passage probability given its advanced stage and bipartisan appropriations process. Caterpillar, Vulcan Materials, and Martin Marietta are structurally positioned to benefit from this direct federal spending.

Sep 10, 2025
CATMLMVMC
BillHR5610neutral

Improving Drought Monitoring Act

The Improving Drought Monitoring Act (H.R. 5610) is an early-stage authorization bill that reauthorizes the U.S. Drought Monitor program through FY2030 and creates an interagency working group to improve in-situ data integration. It contains zero direct spending or procurement mandates, making it a procedural, low-impact bill for public markets. Trimble ($TRMB) is the most structurally exposed public company due to its precision agriculture data platform, but any revenue impact requires future appropriations and is not guaranteed.

Sep 26, 2025
AGCODEGOOGLMSFT
BillS2857neutral

Protecting Free Vaccines Act of 2025

The Protecting Free Vaccines Act of 2025 is an early-stage bill (S.2857) that codifies existing ACIP vaccine coverage mandates through 2030 without expanding coverage, creating new funding, or changing market dynamics. The bill's impact on vaccine manufacturers and insurers is neutral: it removes regulatory uncertainty but provides no growth catalyst. All S&P 500 stocks covered have been declining over the past 30 days, with MRNA down 13.49% in the last week alone. This bill does not alter those trends.

Sep 18, 2025
CVSJNJMRNAPFEUNH
BillHR5448bullish

Protecting Free Vaccines Act

The Protecting Free Vaccines Act (HR5448) is an early-stage House bill that would mandate zero-cost-sharing coverage for ACIP-recommended vaccines across Medicare, Medicaid, CHIP, and private insurance until 2030. Vaccine manufacturers like Pfizer and Moderna are structurally positioned to benefit from increased utilization, while health insurers like UnitedHealth face higher claims costs. CVS has mixed exposure as both insurer (Aetna) and vaccine administrator (CVS Pharmacy). The bill is referred to three committees with 72 cosponsors and has a Senate companion bill (S2857), but a long legislative path remains.

Sep 18, 2025
CVSMRNAPFEUNH
Billneutral

CITIBANK, NATIONAL ASSOCIATION: $184M Department of State Contract

Citibank, National Association, a subsidiary of Citigroup ($C), secured a $184 million contract from the Department of State for an Application Processing Solution. While significant, this contract represents a minor portion of Citigroup's vast annual revenue, indicating a neutral but steady revenue stream.

Sep 30, 2025
AMZNLDOSMSFTTYL
BillHR5605neutral

Medical Device Nonvisual Accessibility Act of 2025

HR5605, the Medical Device Nonvisual Accessibility Act, is in early committee stage with zero appropriation — a compliance mandate, not a spending bill. Home medical device makers face moderate retrofit costs but no immediate revenue impact. Market data shows medtech stocks already under broad 30-day pressure (-8% to -11%), and this bill adds a minor regulatory cost layer without near-term catalyst.

Sep 26, 2025
ABTDXCMTNDM
BillHR747bearish

Stop Chinese Fentanyl Act of 2025

HR747 (Stop Chinese Fentanyl Act) is an early-stage House bill expanding sanctions definitions for Chinese entities involved in opioid precursors. The bill has been reported by committee but faces a long legislative path. Market data shows chemicals ($DD, $ECL) are near 30-day lows while logistics ($UPS, $FDX, $CHRW) have rallied 12-15% in the last month, indicating no market pricing of this bill's risk. Impact score is low at 2 because the bill authorizes zero funding, remains early-stage, and would affect a narrow subset of US-China chemical trade.

Sep 3, 2025
BillHR5454bearish

Medicare Advantage Prompt Pay Act

The Medicare Advantage Prompt Pay Act (HR5454) is early-stage legislation that would mandate MA plans to pay 95% of clean claims within 14 days (electronic in-network) or 30 days (other). This eliminates float income and increases administrative costs for MA insurers. Recent rallies in UNH (+3.3% 7-day), HUM (+12.12%), ELV (+8.12%), MOH (+10.8%), and CVS (+6.9%) appear disconnected from this structural headwind.

Sep 18, 2025
CVSELVHUMMOHUNH

Free — no credit card

Get the next Smith trade the day it's disclosed

HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →

Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.